Howard Brown Health Center

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Pre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV Infection	Pre-Exposure Prophylaxis of HIV Infection	Active, not recruiting	Phase 3	2026-10-06	NCT04925752
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance	HIV-1-infection	Active, not recruiting	Phase 2 / Phase 3	2026-10-01	NCT04150068
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)	HIV Pre-exposure Prophylaxis	Active, not recruiting	Phase 3	2026-08-28	NCT07047716
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen	HIV-1-infection	Active, not recruiting	Phase 2 / Phase 3	2026-08-10	NCT05502341
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1	HIV-1-Infection	Active, not recruiting	Phase 3	2026-05-29	NCT06630299
Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV	HIV-1 Infection	Active, not recruiting	Phase 2	2026-02-04	NCT05052996

Clinical trials